Search Results - "Duygu Derin"

Refine Results
  1. 1

    Intraglomerular crescentic metastases of malignant melanoma by Ozluk, Yasemin, MD, Kilicaslan, Isin, MD, Kazancioglu, Rumeyza, MD, Demirkesen, Cuyan, MD, Derin, Duygu, MD, Mandel, Nil Molinas, MD

    Published in Human pathology (01-12-2011)
    “…Summary We describe here a patient with a metastatic malignant melanoma displaying crescentic lesions in the glomeruli. A 64-year-old woman was referred to our…”
    Get full text
    Journal Article
  2. 2

    A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer by Tas, Faruk, Guney, Nese, Derin, Duygu, Aydiner, Adnan, Topuz, Erkan

    Published in International journal of clinical oncology (01-04-2008)
    “…Background Both gemcitabine and pegylated liposomal doxorubicin (PLD) are antineoplastic drugs with clinical activity in patients with platinum-resistant…”
    Get full text
    Journal Article
  3. 3

    Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer by Tas, Faruk, Derin, Duygu, Guney, Nese, Aydiner, Adnan, Topuz, Erkan

    Published in International journal of clinical oncology (01-08-2008)
    “…Background Pegylated liposomal doxorubicin (PLD) is the only nonplatinum agent to significantly improve survival in patients with platinum-sensitive recurrent…”
    Get full text
    Journal Article
  4. 4

    Effect of kefir on the quality of life of patients being treated for colorectal cancer by Can, Gulbeyaz, Topuz, Erkan, Derin, Duygu, Durna, Zehra, Aydiner, Adnan

    Published in Oncology nursing forum (01-11-2009)
    “…To determine kefir's effect on the prevention of gastrointestinal complaints and quality of life (QOL) in patients being treated for colorectal cancer…”
    Get full text
    Journal Article
  5. 5

    Utility of serum and urine uPAR levels for diagnosis of breast cancer by Soydinc, Hilal Oguz, Duranyildiz, Derya, Guney, Nese, Derin, Duygu, Yasasever, Vildan

    “…Malignant tumors have a capacity to degrade the extracellular matrix by controlled proteolysis. One system involved in these processes is the urokinase-type…”
    Get full text
    Journal Article
  6. 6

    Serum IL-8 and IL-12 levels in breast cancer by Derin, Duygu, Soydinc, Hilal Oguz, Guney, Nese, Tas, Faruk, Camlica, Hakan, Duranyildiz, Derya, Yasasever, Vildan, Topuz, Erkan

    “…Interleukins (ILs) are known to play a fundamental role in cancer. We investigated the serum levels of IL-8 and IL-12, in breast cancer patients, and their…”
    Get full text
    Journal Article
  7. 7

    Serum levels of angiogenic factors in early breast cancer remain close to normal by Duranyildiz, Derya, Camlica, Hakan, Soydinc, Hilal Oguz, Derin, Duygu, Yasasever, Vildan

    Published in Breast (Edinburgh) (01-02-2009)
    “…Abstract The study which we performed was to determine serum concentrations of angiogenic factors including VEGF, angiogenin and TGF-beta 1 in early stage…”
    Get full text
    Journal Article
  8. 8

    Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer by Tas, Faruk, Guney, Nese, Derin, Duygu, Camlica, Hakan, Aydiner, Adnan, Topuz, Erkan

    Published in Investigational new drugs (01-08-2008)
    “…Summary Gemcitabine and cisplatin are the active agents in metastatic breast cancer pretreated with anthracycline and/or taxane as a second line treatment. The…”
    Get full text
    Journal Article
  9. 9

    Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer by Guney, Nese, Soydinc, Hilal Oguz, Derin, Duygu, Tas, Faruk, Camlica, Hakan, Duranyildiz, Derya, Yasasever, Vildan, Topuz, Erkan

    “…Cell adhesion is a basic count in inter- and intra-cellular communication and plays an important role in tumor progression. This study was conducted to…”
    Get full text
    Journal Article
  10. 10

    Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma by Guney, Nese, Soydinc, Hilal Oguz, Basaran, Mert, Bavbek, Sevil, Derin, Duygu, Camlica, Hakan, Yasasever, Vildan, Topuz, Erkan

    “…There exists strong evidence that tumor growth can be actively controlled by the host immune system and interleukins are known to play a significant role in…”
    Get more information
    Journal Article
  11. 11

    Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer by Derin, Duygu, Soydinç, Hilal Oguz, Guney, Nese, Tas, Faruk, Çamlıca, Hakan, Duranyıldız, Derya, Yasasever, Vildan, Topuz, Erkan

    Published in Lung cancer (Amsterdam, Netherlands) (01-02-2008)
    “…Summary Context This study was conducted to investigate the prognostic role and the effects of chemotherapy on serum apoptosis biomarkers consisting of…”
    Get full text
    Journal Article
  12. 12

    Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma by Tas, Faruk, Derin, Duygu, Guney, Nese, Camlica, Hakan, Aydiner, Adnan, Topuz, Erkan

    Published in Lung cancer (Amsterdam, Netherlands) (01-07-2007)
    “…Summary Background Topotecan is an active agent for the management of untreated and recurrent extensive-disease small cell lung cancer (ED-SCLC). This study…”
    Get full text
    Journal Article
  13. 13

    Evaluation of glutathione S-transferase P1 polymorphisms (Ile105Val and Ala114Val) in patients with small cell lung cancer by Vural, Burcak, Yakar, Fatih, Derin, Duygu, Saip, Pınar, Yakar, Aysun, Demirkan, Ayşe, Karabulut, Aydın, Ugurel, Elif, Cine, Naci, Kilicaslan, Zeki, Tüzün, Erdem, Ozbek, Ugur

    Published in Genetic testing and molecular biomarkers (01-07-2012)
    “…Glutathione S-transferase P1 (GSTP1) plays an important role in cellular protection against oxidative stress and toxic chemicals. Polymorphisms within GSTP1…”
    Get more information
    Journal Article
  14. 14

    Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer by Derin, Duygu, Eralp, Yesim, Ozluk, Yasemin, Yavuz, Ekrem, Guney, Nese, Saip, Pinar, Igci, Abdullah, Ozmen, Vahit, Kücücük, Seden, Aslay, Isik, Aydiner, Adnan, Topuz, Erkan

    Published in Cancer investigation (01-01-2008)
    “…Introduction: Hormone receptor negative breast cancer is encountered in about 30% of all patients with breast cancer and is considered as a prognostically…”
    Get full text
    Journal Article
  15. 15

    Serum and urine survivin levels in breast cancer by Guney, Nese, Soydine, Hilal Oguz, Derin, Duygu, Tas, Faruk, Camlica, Hakan, Duranyildiz, Derya, Yasasever, Vildan, Topuz, Erkan

    “…This study was conducted to investigate the serum and urine levels of survivin in patients with breast cancer and the relationships with known prognostic…”
    Get full text
    Journal Article
  16. 16

    Ovarian carcinoma with simultaneous breast and rectum metastases by Derin, Duygu, Eralp, Yeşim, Guney, Nese, Ozlük, Yasemin, Topuz, Erkan

    Published in Onkologie (01-04-2008)
    “…Metastatic involvement of the breast and the rectum from ovarian carcinoma are very rare events. We report a case of ovarian carcinoma with metastasis to the…”
    Get more information
    Journal Article
  17. 17

    Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission by Karagol, Hakan, Derin, Duygu, Basaran, Mert, Bavbek, Sevil

    “…Paranasal sinuses represent an unusual site for non-Hodgkin's lymphoma (NHL). Failure after treatment for paranasal sinus lymphomas is usually in…”
    Get full text
    Journal Article
  18. 18

    Primary tubal cancers: a clinicopathological study of twenty cases by Onder, Semen Yesil, Yavuz, Ekrem, Tuzlali, Sitki, Ilhan, Ridvan, Topuz, Samet, Iyibozkurt, A. Cem, Derin, Duygu, Eralp, Yesim

    Published in Türk patoloji dergisi (2009)
    “…Amaç: Primer tuba kanserleri, tüm jinekolojik sistem malignitelerinin %1'inden azını oluşturan nadir tümörlerdir. Bu çalışmada, anabilim dalımızda primer tuba…”
    Get full text
    Journal Article
  19. 19
  20. 20